In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Going Once, Going Twice…

This article was originally published in Start Up

Executive Summary

George Pieczenik, PhD, just got a patent that he insists is critical to the field of combinatorial chemistry. It covers the use of molecular libraries for screening. He and partner David Chassen believe it is so important that they are proceeding wth an unusual licensing strategy--they are planning to hold a series of auctions over the Internet for exclusive rights to the patent for particular screening applications. So far biotech companies don't seem to know much about the patent and those which have heard of it aren't paying it much attention. The auction will say something about how others perceive the value of the patent


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts